LAMEA Rabies Vaccine Market Size, Share & Trends Analysis Report By Prophylaxis Type (Post-exposure Prophylaxis, and Pre-exposure prophylaxis), By End User, By Application (Human, and Animal), By Product Type, By Country and Growth Forecast, 2023 - 2030

The Latin America, Middle East and Africa Rabies Vaccine Market would witness market growth of 7.0% CAGR during the forecast period (2023-2030).

The Brazil market dominated the LAMEA Rabies Vaccine Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $33.5 Million by 2030. The Argentina market is showcasing a CAGR of 7.6% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 6.6% during (2023 - 2030).

Ongoing research focuses on improving the formulation of these vaccines to enhance their efficacy and duration of immunity. Novel adjuvants and vaccine platforms are being explored to stimulate a robust and long-lasting immune response. These advancements aim to optimize the effectiveness of rabies vaccination campaigns and reduce the frequency of booster doses, particularly in resource-constrained settings.

Technology plays a crucial role in modernizing rabies prevention efforts. Digital health solutions, including mobile applications and digital platforms, are increasingly used for surveillance, reporting, and monitoring of rabies cases. Real-time data collection allows for more agile responses to outbreaks, facilitates targeted vaccination campaigns, and contributes to the overall efficiency of rabies control programs.

Saudi Arabia enforces mandatory pet vaccination policies, requiring pet owners to ensure their animals are vaccinated against rabies. Implementing these policies contributes to a consistent demand for these vaccines, particularly in urban and suburban areas with a higher pet population in Saudi Arabia. The increasing trend of pet ownership in Saudi Arabia, particularly in urban areas, contributes to the demand for these vaccines. As more households adopt pets, responsible ownership practices, including vaccination, become integral to the well-being of animals and public health in Saudi Arabia. As a global hub, Saudi Arabia experiences cross-border travel with pets and imports of animals. Cultural values in Saudi Arabia emphasize the importance of animal welfare. Thus, due to these aspects, the market will expand across the LAMEA region in upcoming years.

Free Valuable Insights: The Worldwide Rabies Vaccine Market is Projected to reach USD 1.6 Billion by 2030, at a CAGR of 4.5%

Based on Prophylaxis Type, the market is segmented into Post-exposure Prophylaxis, and Pre-exposure prophylaxis. Based on End User, the market is segmented into Hospitals, Veterinary Clinics, and Others. Based on Application, the market is segmented into Human, and Animal. Based on Product Type, the market is segmented into Chick Embryo Cells Rabies Vaccine, Human Diploid Cell Vaccine, Vero cell rabies vaccine, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

• Boehringer Ingelheim International GmbH
• Cadila Pharmaceuticals Limited
• Serum Institute of India Pvt. Ltd. (Cyrus Poonawalla Group)
• Elanco Animal Health, Inc.
• Zoetis, Inc.
• Merck & Co., Inc.
• Novartis AG
• Bharat Biotech Ltd.
• Sanofi S.A.
• Virbac

LAMEA Rabies Vaccine Market Report Segmentation

By Prophylaxis Type

• Post-exposure Prophylaxis
• Pre-exposure prophylaxis

By End User

• Hospitals
• Veterinary Clinics
• Others

By Application

• Human
• Animal

By Product Type

• Chick Embryo Cells Rabies Vaccine
• Human Diploid Cell Vaccine
• Vero cell rabies vaccine
• Others

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Rabies Vaccine Market, by Prophylaxis Type
1.4.2 LAMEA Rabies Vaccine Market, by End User
1.4.3 LAMEA Rabies Vaccine Market, by Application
1.4.4 LAMEA Rabies Vaccine Market, by Product Type
1.4.5 LAMEA Rabies Vaccine Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. LAMEA Rabies Vaccine Market by Prophylaxis Type
4.1 LAMEA Post-exposure Prophylaxis Market by Country
4.2 LAMEA Pre-exposure prophylaxis Market by Country

Chapter 5. LAMEA Rabies Vaccine Market by End User
5.1 LAMEA Hospitals Market by Country
5.2 LAMEA Veterinary Clinics Market by Country
5.3 LAMEA Others Market by Country

Chapter 6. LAMEA Rabies Vaccine Market by Application
6.1 LAMEA Human Market by Country
6.2 LAMEA Animal Market by Country

Chapter 7. LAMEA Rabies Vaccine Market by Product Type
7.1 LAMEA Chick Embryo Cells Rabies Vaccine Market by Country
7.2 LAMEA Human Diploid Cell Vaccine Market by Country
7.3 LAMEA Vero Cell Rabies Vaccine Market by Country
7.4 LAMEA Others Market by Country

Chapter 8. LAMEA Rabies Vaccine Market by Country
8.1 Brazil Rabies Vaccine Market
8.1.1 Brazil Rabies Vaccine Market by Prophylaxis Type
8.1.2 Brazil Rabies Vaccine Market by End User
8.1.3 Brazil Rabies Vaccine Market by Application
8.1.4 Brazil Rabies Vaccine Market by Product Type
8.2 Argentina Rabies Vaccine Market
8.2.1 Argentina Rabies Vaccine Market by Prophylaxis Type
8.2.2 Argentina Rabies Vaccine Market by End User
8.2.3 Argentina Rabies Vaccine Market by Application
8.2.4 Argentina Rabies Vaccine Market by Product Type
8.3 UAE Rabies Vaccine Market
8.3.1 UAE Rabies Vaccine Market by Prophylaxis Type
8.3.2 UAE Rabies Vaccine Market by End User
8.3.3 UAE Rabies Vaccine Market by Application
8.3.4 UAE Rabies Vaccine Market by Product Type
8.4 Saudi Arabia Rabies Vaccine Market
8.4.1 Saudi Arabia Rabies Vaccine Market by Prophylaxis Type
8.4.2 Saudi Arabia Rabies Vaccine Market by End User
8.4.3 Saudi Arabia Rabies Vaccine Market by Application
8.4.4 Saudi Arabia Rabies Vaccine Market by Product Type
8.5 South Africa Rabies Vaccine Market
8.5.1 South Africa Rabies Vaccine Market by Prophylaxis Type
8.5.2 South Africa Rabies Vaccine Market by End User
8.5.3 South Africa Rabies Vaccine Market by Application
8.5.4 South Africa Rabies Vaccine Market by Product Type
8.6 Nigeria Rabies Vaccine Market
8.6.1 Nigeria Rabies Vaccine Market by Prophylaxis Type
8.6.2 Nigeria Rabies Vaccine Market by End User
8.6.3 Nigeria Rabies Vaccine Market by Application
8.6.4 Nigeria Rabies Vaccine Market by Product Type
8.7 Rest of LAMEA Rabies Vaccine Market
8.7.1 Rest of LAMEA Rabies Vaccine Market by Prophylaxis Type
8.7.2 Rest of LAMEA Rabies Vaccine Market by End User
8.7.3 Rest of LAMEA Rabies Vaccine Market by Application
8.7.4 Rest of LAMEA Rabies Vaccine Market by Product Type

Chapter 9. Company Profiles
9.1 Cadila Pharmaceuticals Limited
9.1.1 Company Overview
9.1.2 Recent strategies and developments:
9.1.2.1 Product Launches and Product Expansions:
9.2 Bharat Biotech Ltd.
9.2.1 Company Overview
9.3 Serum Institute of India Pvt. Ltd. (Cyrus Poonawalla Group)
9.3.1 Company Overview
9.4 Boehringer Ingelheim International GmbH
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional & Segmental Analysis
9.4.4 Research & Development Expenses
9.4.5 SWOT Analysis
9.5 Elanco Animal Health, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 Research & Development Expense
9.5.5 SWOT Analysis
9.6 Zoetis, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.6.5 SWOT Analysis
9.7 Merck & Co., Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 SWOT Analysis
9.8 Novartis AG
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 SWOT Analysis
9.9 Sanofi S.A.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 SWOT Analysis
9.10. Virbac
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Regional Analysis
9.10.4 SWOT Analysis

TABLE 1 LAMEA Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 2 LAMEA Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 3 LAMEA Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 4 LAMEA Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 5 LAMEA Post-exposure Prophylaxis Market by Country, 2019 - 2022, USD Million
TABLE 6 LAMEA Post-exposure Prophylaxis Market by Country, 2023 - 2030, USD Million
TABLE 7 LAMEA Pre-exposure prophylaxis Market by Country, 2019 - 2022, USD Million
TABLE 8 LAMEA Pre-exposure prophylaxis Market by Country, 2023 - 2030, USD Million
TABLE 9 LAMEA Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 10 LAMEA Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 11 LAMEA Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 12 LAMEA Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 13 LAMEA Veterinary Clinics Market by Country, 2019 - 2022, USD Million
TABLE 14 LAMEA Veterinary Clinics Market by Country, 2023 - 2030, USD Million
TABLE 15 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 16 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 17 LAMEA Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 18 LAMEA Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 19 LAMEA Human Market by Country, 2019 - 2022, USD Million
TABLE 20 LAMEA Human Market by Country, 2023 - 2030, USD Million
TABLE 21 LAMEA Animal Market by Country, 2019 - 2022, USD Million
TABLE 22 LAMEA Animal Market by Country, 2023 - 2030, USD Million
TABLE 23 LAMEA Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 24 LAMEA Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 25 LAMEA Chick Embryo Cells Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 26 LAMEA Chick Embryo Cells Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 27 LAMEA Human Diploid Cell Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 28 LAMEA Human Diploid Cell Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 29 LAMEA Vero Cell Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 30 LAMEA Vero Cell Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 31 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 32 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 33 LAMEA Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 34 LAMEA Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 35 Brazil Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 36 Brazil Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 37 Brazil Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 38 Brazil Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 39 Brazil Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 40 Brazil Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 41 Brazil Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 42 Brazil Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 43 Brazil Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 44 Brazil Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 45 Argentina Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 46 Argentina Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 47 Argentina Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 48 Argentina Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 49 Argentina Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 50 Argentina Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 51 Argentina Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 52 Argentina Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 53 Argentina Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 54 Argentina Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 55 UAE Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 56 UAE Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 57 UAE Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 58 UAE Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 59 UAE Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 60 UAE Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 61 UAE Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 62 UAE Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 63 UAE Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 64 UAE Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 65 Saudi Arabia Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 66 Saudi Arabia Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 67 Saudi Arabia Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 68 Saudi Arabia Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 69 Saudi Arabia Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 70 Saudi Arabia Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 71 Saudi Arabia Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 72 Saudi Arabia Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 73 Saudi Arabia Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 74 Saudi Arabia Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 75 South Africa Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 76 South Africa Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 77 South Africa Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 78 South Africa Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 79 South Africa Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 80 South Africa Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 81 South Africa Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 82 South Africa Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 83 South Africa Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 84 South Africa Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 85 Nigeria Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 86 Nigeria Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 87 Nigeria Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 88 Nigeria Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 89 Nigeria Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 90 Nigeria Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 91 Nigeria Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 92 Nigeria Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 93 Nigeria Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 94 Nigeria Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 95 Rest of LAMEA Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 96 Rest of LAMEA Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 97 Rest of LAMEA Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 98 Rest of LAMEA Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 99 Rest of LAMEA Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 100 Rest of LAMEA Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 101 Rest of LAMEA Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 102 Rest of LAMEA Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 103 Rest of LAMEA Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 104 Rest of LAMEA Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 105 Key Information – Cadila Pharmaceuticals Limited
TABLE 106 Key Information – Bharat Biotech Ltd.
TABLE 107 Key Information – Serum Institute of India Pvt. Ltd.
TABLE 108 Key Information – Boehringer Ingelheim International GmbH
TABLE 109 Key information – Elanco Animal Health, Inc.
TABLE 110 Key Information – Zoetis, Inc.
TABLE 111 Key Information - Merck & Co., Inc.
TABLE 112 Key Information – Novartis AG
TABLE 113 Key Information – Sanofi S.A.
TABLE 114 Key Information – Virbac

List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA Rabies Vaccine Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Rabies Vaccine Market
FIG 4 Porter’s Five Forces Analysis – Rabies Vaccine Market
FIG 5 LAMEA Rabies Vaccine Market share by Prophylaxis Type, 2022
FIG 6 LAMEA Rabies Vaccine Market share by Prophylaxis Type, 2030
FIG 7 LAMEA Rabies Vaccine Market by Prophylaxis Type, 2019 - 2030, USD Million
FIG 8 LAMEA Rabies Vaccine Market share by End User, 2022
FIG 9 LAMEA Rabies Vaccine Market share by End User, 2030
FIG 10 LAMEA Rabies Vaccine Market by End User, 2019 - 2030, USD Million
FIG 11 LAMEA Rabies Vaccine Market share by Application, 2022
FIG 12 LAMEA Rabies Vaccine Market share by Application, 2030
FIG 13 LAMEA Rabies Vaccine Market by Application, 2019 - 2030, USD Million
FIG 14 LAMEA Rabies Vaccine Market share by Product Type, 2022
FIG 15 LAMEA Rabies Vaccine Market share by Product Type, 2030
FIG 16 LAMEA Rabies Vaccine Market by Product Type, 2019 - 2030, USD Million
FIG 17 LAMEA Rabies Vaccine Market share by Country, 2022
FIG 18 LAMEA Rabies Vaccine Market share by Country, 2030
FIG 19 LAMEA Rabies Vaccine Market by Country, 2019 - 2030, USD Million
FIG 20 SWOT Analysis: Boehringer Ingelheim International GmbH
FIG 21 SWOT Analysis: Elanco Animal Health, Inc.
FIG 22 Swot Analysis: ZOETIS, INC.
FIG 23 SWOT Analysis: Merck & Co., Inc.
FIG 24 SWOT Analysis: Novartis AG
FIG 25 Swot Analysis: Sanofi S.A.
FIG 26 SWOT Analysis: Virbac